Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina. *Corresponding Author: Brent A. Hanks, Lineberger Comprehensive Cancer Center, University of North ...
Cancer Res (2025) 85 (8_Supplement_2): ND11.
Cancer Res (2025) 85 (8_Supplement_2): CT112.
Abstract. Paraptosis is a type of programmed cell death characterized by cytoplasmic vacuolation, merging as a potential therapeutic strategy for cancer treatment. Paraptosis has been associated with ...
The combination of anti-TROP2 ADCs with PD-(L)1 inhibitors represents a promising therapeutic strategy, merging targeted therapy with immunotherapy to improve treatment outcomes. Clinical trials are ...
Search for other works by this author on: ...
Search for other works by this author on: ...
MediLink Therapeutics (Suzhou) Co., Ltd., Suzhou, China.
Search for other works by this author on: ...
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio (avelumab), a ...
Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results